Physician profile
Bradley Moore
NPI 1699744847
$2,336.12
in general payments reported to CMS, 2019-2025
33 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $178 · 2021: $365 · 2022: $432 · 2023: $421 · 2024: $320 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.77 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $260.89 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $197.46 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $170.87 | 2019-2025 | |
| Pfizer INC. | $92.56 | 2024-2025 | |
| Evofem Biosciences, INC. | $92.13 | 2021-2024 | Phexxi |
| Mayne Pharma Commercial LLC | $82.24 | 2021-2024 | |
| Millicent US INC | $81.81 | 2020-2025 | Femlyv |
| Myovant Sciences INC. | $81.43 | 2021-2022 | |
| Therapeuticsmd, INC. | $79.81 | 2019-2022 | |
| Avion Pharmaceuticals | $74.91 | 2019-2022 | |
| Dysis Medical, INC. | $71.90 | 2021-2022 | |
| Channel Medsystems, INC. | $65.65 | 2023 | |
| Optumhealth Care Solutions, LLC | $53.09 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Aspira Women'S Health INC | $50.56 | 2020-2024 | Ova1 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $47.51 | 2025 | Arista |
| Coopersurgical, INC. | $42.53 | 2020-2022 | |
| Agile Therapeutics, INC. | $34.20 | 2021-2022 | |
| Dexcom, INC. | $27.52 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $26.71 | 2024 | Zurzuvae |
| Medicem INC. | $26.52 | 2020 | |
| Meditrina | $26.00 | 2023 | |
| Allergan, INC. | $25.63 | 2019 | |
| Organon LLC | $21.26 | 2022 | |
| Glaxosmithkline, LLC. | $20.17 | 2020 | |
| Vertical Pharmaceuticals, LLC | $19.97 | 2019 | |
| Shield Therapeutics INC | $19.95 | 2022 | |
| Roche Diagnostics Corporation | $18.04 | 2019 | |
| Mission Pharmacal Company | $16.77 | 2021 | |
| Lupin INC. | $15.87 | 2019 | |
| Lsi Solutions INC | $15.74 | 2024 | Ti-Knot, Running Device, Fornisee |
| Mylan Pharmaceuticals INC. | $14.65 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.